|
⚲
|
| Keyboard |
| David Cordo | |
|---|---|
| Firm | |
| Address | 1030 Massachusetts Avenue Suite 210 Cambridge, MA 02138 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Werewolf Therapeutics Inc | 021-385514 | Executive Officer | 72.1 M of 72.1 M |
||
| Werewolf Therapeutics Inc | 021-346661 | Executive Officer | 56.2 M of 56.2 M |
||
| Ally Therapeutics Inc | 021-346178 | Executive Officer | 10.0 M of 11.0 M |
||
| Ribon Therapeutics Inc | 021-329723 | Executive Officer | 25.4 M of 65.0 M |
||
| Potenza Therapeutics Inc | 021-301945 | Executive Officer | 5.0 M of 5.0 M |
||
| Ribon Therapeutics Inc | 021-296259 | Executive Officer | 20.0 M of 20.0 M |
||
| Trieza Therapeutics Inc | 021-275662 | Executive Officer | 6.0 M of 6.0 M |
||
| Trieza Therapeutics Inc | 021-275660 | Executive Officer | 0.0 M of 0.0 M |
||
| Vesuvius Pharmaceuticals Inc | 021-231374 | Executive Officer | 10.2 M of 33.0 M |
||
| Potenza Therapeutics Inc | 021-229558 | Executive Officer | 30.0 M of 38.0 M |
||
| Mitokyne Inc | 021-204791 | Executive Officer | 5.2 M of 45.0 M |
||
| Metamark Genetics Inc | 021-187034 | Executive Officer | 9.1 M of 9.1 M |
||
| Metamark Genetics Inc | 021-144637 | Executive Officer | 22.1 M of 42.1 M |
||